BR0211049A - Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae - Google Patents

Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae

Info

Publication number
BR0211049A
BR0211049A BR0211049-0A BR0211049A BR0211049A BR 0211049 A BR0211049 A BR 0211049A BR 0211049 A BR0211049 A BR 0211049A BR 0211049 A BR0211049 A BR 0211049A
Authority
BR
Brazil
Prior art keywords
vaccine
prevention
treatment
mycoplasma hyopneumoniae
hyo
Prior art date
Application number
BR0211049-0A
Other languages
English (en)
Inventor
Alexander Crossan Goudie
Andrew Raymond Peters
Robin Lee Keich
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0211049A publication Critical patent/BR0211049A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"MéTODO DE TRATAMENTO OU PREVENçãO DE DOENçAS OU DISFUNçõES E USO DE MYCOPLASMA HYOPNEUMONIAE". A presente invenção refere-se ao tratamento ou prevenção de doenças ou disfunções em animais causadas pela infecção por Mycoplasma bovis (M. bovis) através da administração ao animal de quantidade eficaz de uma vacina de Mycoplasma hyopneumoniae (M. hyo). A vacina de M. hyo pode ser uma preparação viva inativada ou modificada de células inteiras ou parciais, uma vacina de subunidades ou uma vacina de DNA ou ácido nucléico. A vacina de M. hyo administrada de acordo com a presente invenção pode ser sintetizada ou produzida de forma recombinante.
BR0211049-0A 2001-07-02 2002-05-30 Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae BR0211049A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30258601P 2001-07-02 2001-07-02
PCT/IB2002/001937 WO2003004051A2 (en) 2001-07-02 2002-05-30 Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle

Publications (1)

Publication Number Publication Date
BR0211049A true BR0211049A (pt) 2004-07-20

Family

ID=23168382

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0211049-0A BR0211049A (pt) 2001-07-02 2002-05-30 Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae

Country Status (9)

Country Link
US (1) US7056492B2 (pt)
EP (1) EP1521592A2 (pt)
JP (1) JP2004537543A (pt)
CN (1) CN1612749A (pt)
AR (1) AR034677A1 (pt)
BR (1) BR0211049A (pt)
CA (1) CA2452666A1 (pt)
MX (1) MXPA03011924A (pt)
WO (1) WO2003004051A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003017755A2 (en) * 2001-08-28 2003-03-06 Pfizer Products Inc. Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
AR069087A1 (es) 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
DK2217271T3 (en) * 2007-11-06 2016-06-06 Zoetis Services Llc Avirulent, live vaccine with adjuvant against Mycoplasma hyopneumoniae
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
WO2009156960A2 (en) 2008-06-27 2009-12-30 Pfizer Inc. Novel adjuvant compositions
US8815255B2 (en) * 2008-10-31 2014-08-26 Boehringer Ingelheim Vetmedica, Inc. Use of Mycoplasma bovis antigen
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
AU2010251761B2 (en) * 2009-05-19 2014-10-09 Bioproperties Pty Ltd A temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof
TWI583403B (zh) 2009-06-04 2017-05-21 國立感染症研究所 黴漿菌感染症用疫苗
EP2654785B1 (en) * 2010-12-22 2019-03-20 Bayer Intellectual Property GmbH Enhanced immune response in bovine species
UA115053C2 (uk) * 2012-03-07 2017-09-11 Сева Санте Анімаль Композиція, що містить антиген і ліпополісахарид у формі масло-в-воді, та спосіб її використання (варіанти)
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
AU2013370983B2 (en) 2012-12-28 2019-09-26 Boehringer Ingelheim Vetmedica Gmbh Method of making a mycoplasma vaccine
UA121097C2 (uk) * 2012-12-28 2020-04-10 Бьорінгер Інгельхайм Ветмедіка Гмбх Імуногенна композиція, що містить антигени мікоплазм
WO2015035474A1 (en) * 2013-09-16 2015-03-19 The University Of Melbourne Serological test
JP6586083B2 (ja) 2013-09-19 2019-10-02 ゾエティス・サービシーズ・エルエルシー 油性アジュバント
ES2714000T3 (es) 2013-11-21 2019-05-24 Agricultural Tech Res Inst Composición para prevenir y curar una infección por micoplasma
MX2016010993A (es) 2014-02-28 2017-05-01 Bayer Animal Health Gmbh Plasmidos inmunoestimuladores.
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
KR20170097116A (ko) 2015-01-16 2017-08-25 조에티스 서비시즈 엘엘씨 구제역 백신
US10279031B2 (en) 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
CN111856005B (zh) * 2020-06-22 2021-07-30 华中农业大学 牛支原体分泌蛋白MbovP280的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT65827A (en) * 1990-04-02 1994-07-28 Synergen Inc Polypeptides useful in animal treatment against mycoplasma infections
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US5788962A (en) * 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures

Also Published As

Publication number Publication date
WO2003004051A2 (en) 2003-01-16
WO2003004051A3 (en) 2005-02-17
CA2452666A1 (en) 2003-01-16
US20030064079A1 (en) 2003-04-03
AR034677A1 (es) 2004-03-03
US7056492B2 (en) 2006-06-06
JP2004537543A (ja) 2004-12-16
MXPA03011924A (es) 2004-03-26
CN1612749A (zh) 2005-05-04
EP1521592A2 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
BR0211049A (pt) Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae
BR0210804A (pt) Vacinação de dose única com mycoplásma hyopneumoniae
BR0210798A (pt) vacinas de mycoplasma bovis e métodos de redução de pneumonia em animais
BRPI0010612B8 (pt) vacinas
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
BR9909483A (pt) Derivados de proteìnas ligantes pneumococcal colina para vacinas
BR0111916A (pt) Métodos e composição para vacinação oral
BR0315319A (pt) Terapias e procedimentos dentais com toxina botulìnica
BR9611623A (pt) Composição de vacina e processo para a profilaxia ou tratamento de infecção em um animal ou pássaro por lawsonia intracelularis ou microorganismo relacionado, molécula de ácido nucleico isolada, e, vacina genética.
BR0110971A (pt) Composições e métodos para tratamento de infecções das mucosas
BR0211563A (pt) Modelo de infecção por mycoplasma bovis e métodos para administração de m. bovis e para indução de lesões pneumÈnicas do pulmão
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
RU2258501C2 (ru) Способ применения этидия бромистого для лечения пироплазмоза лошадей
TH64472A (th) การให้วัคซีนขนาดยาเดียวที่มี Mycoplasma Hyopneumoniae
RU2213573C2 (ru) Способ профилактики паратифа телят
RU2230505C2 (ru) Способ профилактики туберкулеза крупного рогатого скота
BR0002381A (pt) Agente para aumentar a liberação de acetilcolina no cérebro
Santiago Slow progress on HIV vaccines
JP2004262847A (ja) ワクチン製剤
Tarr, AF, O'Grady, JM & Jenkins Rabies in South Africa: rabies and the private practioner
Coates Keep your horse on its feet & feeding
RU2001124669A (ru) Способ профилактики паратифа телят
BR0314668A (pt) Utilização de excipientes para aumentar a captação de dna por células musculares de suìno
TH77235A (th) วัคซีน Mycoplasma bovis และวิธีสำหรับการลดปอดบวมในสัตว์
UA60829A (uk) Спосіб лікування орнітозу

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2060 DE 29/06/2010.